Patents by Inventor Harry Quigley

Harry Quigley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR SUSTAINED RELEASE OF ANTI-GLAUCOMA AGENTS TO CONTROL INTRAOCULAR PRESSURE
    Publication number: 20190022016
    Abstract: Controlled release microparticular formulations for the delivery of active agents, especially for treatment of eye diseases or disorders, such as glaucoma, have been developed. These provide release of the active agent, such as a hydrophilic carbonic anhydride inhibitor, for an effective period of time such as a least one month after injection into the eye for treatment of glaucoma.
    Type: Application
    Filed: March 2, 2017
    Publication date: January 24, 2019
    Inventors: Jie Fu, Ian Pitha, Harry Quigley, Justin Hanes
  • Compositions and methods for treatment of neurodegenerative disease
    Patent number: 9655882
    Abstract: Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: May 23, 2017
    Assignee: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Donald J. Zack, Zhiyong Yang, Cynthia Berlinicke, Harry Quigley
  • COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASE
    Publication number: 20150258061
    Abstract: Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
    Type: Application
    Filed: February 19, 2015
    Publication date: September 17, 2015
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: DONALD J. ZACK, ZHIYONG YANG, CYNTHIA BERLINICKE, HARRY QUIGLEY
  • Compositions and methods for treatment of neurodegenerative disease
    Patent number: 8993615
    Abstract: Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
    Type: Grant
    Filed: August 8, 2009
    Date of Patent: March 31, 2015
    Assignee: The Johns Hopkins University
    Inventors: Donald J. Zack, Zhiyong Yang, Cynthia Berlinicke, Harry Quigley
  • COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASE
    Publication number: 20110172206
    Abstract: Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
    Type: Application
    Filed: August 8, 2009
    Publication date: July 14, 2011
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Donald Jeffrey Zack, Zhiyong Yang, Cynthia Berlinicke, Harry Quigley
  • Neuronal and optic nerve gene expression patterns
    Publication number: 20040081652
    Abstract: The optic nerve axotomy model in mouse exhibits rapid changes in gene expression. Genes identified by microarray analysis as differentially expressed or modulated in this model, can be used diagnostically, therapeutically, and in drug discovery. These results provide clues to underlying molecular processes occurring during optic nerve degeneration, and provide direction for future cell-based studies.
    Type: Application
    Filed: July 14, 2003
    Publication date: April 29, 2004
    Applicant: The Johns Hopkins University
    Inventors: Donald Jeffery Zack, Harry A. Quigley